DLGAP1 and Alzheimer disease: Another protein within the DLGAP family, DLGAP1 (also known as GKAP) is a nominated AD drug target on the Agora platform, which is a database of nominated targets for AD therapeutics, and increased expression is predicted to be protective, similar to DLGAP2 [164].